TELA Bio Inc.
TELA | NASDAQ
$1.31
+$0.01 (+0.77%)
Sep 22, 2026, 11:18 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 80.28M | 69.3M | 58.45M | 41.42M | 29.46M | 18.21M |
Cost of Revenue | 25.93M | 22.81M | 18.34M | 14.37M | 10.65M | 6.98M |
Gross Profit | 54.34M | 46.49M | 40.11M | 27.04M | 18.81M | 11.23M |
Operating Income | -33.76M | -34.12M | -44.08M | -39.01M | -29.45M | -25.28M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -38.6M | -37.99M | -46.66M | -44.3M | -33.28M | -28.79M |
Net Income | -38.83M | -37.84M | -46.66M | -44.3M | -33.28M | -28.79M |
Selling & General & Admin | 78.88M | 79.37M | 74.57M | 57.11M | 41.52M | 32.25M |
Research & Development | 9.22M | 8.81M | 9.62M | 8.94M | 6.74M | 4.26M |
Other Expenses | n/a | -7.58M | n/a | n/a | n/a | n/a |
Operating Expenses | 88.1M | 80.6M | 84.19M | 66.05M | 48.26M | 36.51M |
Interest Expense | 5.25M | 5.29M | 5.22M | 4.05M | 3.6M | 3.56M |
Selling & Marketing Expenses | 63.18M | 64.65M | 59.68M | 43.25M | 29.06M | 22.11M |
Cost & Expenses | 114.03M | 103.42M | 102.53M | 80.43M | 58.91M | 43.49M |
Income Tax Expense | 230K | -144K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 46.95M | 28.53M | 22.87M | 16.27M | 14.47M | 12.93M |
Shares Outstanding (Diluted) | 46.95M | 28.53M | 22.87M | 16.27M | 14.47M | 12.93M |
EPS (Basic) | -0.83 | -1.33 | -2.04 | -2.73 | -2.30 | -2.23 |
EPS (Diluted) | -0.83 | -1.33 | -2.04 | -2.73 | -2.30 | -2.23 |
EBITDA | -32.35M | -31.68M | -40.63M | -39.06M | -29.14M | -24.71M |
EBIT | -33.36M | -32.7M | -41.44M | -40.25M | -29.68M | -25.23M |
Depreciation & Amortization | 1.01M | 1.01M | 808K | 1.19M | 535K | 525K |
Add to Watchlist
Select watchlists to add or remove TELA